BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia

Nikolaus Plesnila(Munich Cluster for Systems Neurology), Michael A. Moskowitz(Massachusetts General Hospital), Daniel S. Kohane(Boston Children's Hospital), Alberto Chiarugi(University of Florence), Yonqin Wu(Howard Hughes Medical Institute), Sepideh Amin‐Hanjani(Howard Hughes Medical Institute), Stanley J. Korsmeyer(Harvard University), Dean A. Le(Howard Hughes Medical Institute), Sunu S. Thomas(Howard Hughes Medical Institute), Jianhua Qiu(Boston Children's Hospital), Sandra S. Zinkel(Vanderbilt University)
Proceedings of the National Academy of Sciences
December 11, 2001
10.1073/pnas.261323298
Cited by 251

Related Papers

Hydrogels in drug delivery: Progress and challenges
|Polymer|2008|3.7k
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
|Nature|2005|3.4k
Nanotechnological strategies for engineering complex tissues
|Nature Nanotechnology|2010|1.4k
Engineering vascularized skeletal muscle tissue
|Nature Biotechnology|2005|1.3k
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
|Genes & Development|2000|1.3k